The data suggest that the inoculated Colon26 cells activate mouse blood coagulation, and EDX suppresses factor Xa-dependent PAR2 activation of cancer and peri-cancer cells involved in tumor tissue growth. This evidence concerns the gene F2RL1 and neoplasm.